Anti-Obesity Effect of Arq Zeera and Its Main Components Thymol and Cuminaldehyde in High Fat Diet Induced Obese Rats

Abstract

Arq zeera is a distillate product that prepared from four different herbs namely Trachyspermum ammi L., apiaceae, Zingiber officinale Roxb., zingiberaceae, Carum carvi L.,apiaceae and Cuminum cyminum L., apiaceae. The present study aims to determine the antiobesity effect of arq zeera and its main components thymol and cuminaldehyde in high fat diet induced obese rats and to explore its mechanism of action. In current study, orlistat was used as positive controls. Male Wistar rats were fed with HFD for 42 days to induce obesity. HFD-fed rats were administered with arq zeera, thymol, cumic aldehyde, thymol + cuminaldehyde and orlistat for 28 days. During the course of treatment, body weight and food intake frequently observed and after end of treatments, liver weight, visceral fat pad weight, plasma lipid proflie, alanine aminotransferase, aspartate aminotransferase, glucose, insulin, leptin levels and pancreatic lipase activity were studied on all treated obese rats. The histopathology of liver was also studied. After the treatments of arq zeera and its main components, body weight, food intake, liver weight, visceral fat pad weight and the level of lipid profile, alanine aminotransferase, aspartate aminotranferase, glucose, insulin, and leptin were found to be decreased and pancreatic lipase inhibition were increased. Arq zeera showed more potential antiobesity effect than orlistat. According to our present findings, arq zeera and its main components possessed potent antiobesity effect on high fat diet -induced obese rats and excreted anti-obesity effect partly via hypolipidemic, hypoglycemic, hypoinsulinemic, hypoleptinemic and pancreatic lipase inhibition action.

Key words

Arq zeera - thymol - cuminaldehyde - obesity - high fat diet - orlistat

• References

• 1 Zhang Y, Guo K, LeBlanc ER. et al. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes 2007; 56: 1447-1453
• 2 Hedley AA, Ogden CL, Johnson CL. et al. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 2004; 291: 2847-2850
• 3 George A. Bray Louis A. Medicinal strategies in the treatment of obesity. Nature 2000; 404: 672-677
• 4 Park HS, Park CY, Oh SW. et al. Prevalence of obesity and metabolic syndrome in Korean adults. Obes Rev 9 2008; 9: 104-107
• 5 Kang JG, Park CY. Anti-obesity drugs: A review about their effects and safety. J Diabetes Metab 2012; 37: 13-25
• 6 Tsigosa C, Hainer V, Basdevant A. et al. Management of obesity in adults: european clinical practice guidelines. Obes Facts 1 2008; 1 106-116
• 7 Xie JT, Zhou YP, Dey L. et al. Ginseng berry reduces blood glucose and body weight in db/db mice. Phytomedicine 2002; 9: 254-258
• 8 Gupta P, Mehla J, Gupta YK. Antiobesity effect of Saffoof-e-Muhazzil, a Unani herbal formulation, in cafeteria diet induced obesity in rats. Indian J Exp Biol 2012; 50: 776-784
• 9 Gurpreet K, Kulkarni SK. Antiobesity effect of a polyherbal formulation, ob-200 g in female rats fed on cafeteria and atherogenic diets. Indian J Pharmacol 2002; 32: 294-295
• 10 Suresha B, Hariprasad M, Rema R. et al. Antiobesity effect of Lipovedic formulation in rats fed on atherogenic diet. Internet J Nutr Wellness 2009; 8 doi: 10.5580/23ff
• 11 National Formulary of Unani Medicine. Government of India and Ministry of Health and Family Welfare (Department of AYUSH). Volume 1, Part (V), 2008; PP-138
• 12 Gupta P, Mehla J, Gupta YK. Antiobesity effect of Saffoof-e-Muhazzil, a Unani herbal formulation, in cafeteria diet induced obesity in rats. Indian J Exp Biol 2012; 50: 776-784
• 13 Joshi SG. Medicinal plants: Family apiaceae. 1st ed. Delhi: Oxford and IBH Publishing Co. Pvt. Ltd; 2000
• 14 Sivarajan VV, Balachandran I. Ayurvedic Drugs and their Plant Sources. New Delhi: Oxford and IBH Publication; 1994
• 15 Guarda A, Javiera F. Rubilar et al. The antimicrobial activity of microen capsulated thymol and caryacrol. Int J Food Microbiol 2011; 146: 144-150
• 16 Riella KR, Marinho RR, Santos JS. et al. Anti-inflammatory and cicatrizing activities of thymol a monoterpene of the essential oil fromLippia gracilis, in rodents. J Ethnopharmacol. 2012; 143: 656-663
• 17 Aftab K, Rahman A, Ghani KU. Blood pressure lowering action of active principle from Trachyspermum ammi (L) Sprague. Phytomedicine 1995; 2: 35-40
• 18 Case GL, He L, Mo H. et al. Induction of geranyl pyrophosphate pyrophosphatase activity by cholesterol-suppressive isoprenoids. Lipids 1995; 30: 357-359
• 19 Chen Q, Hu X, Li J. et al. Preparative isolation and purification of cuminaldehyde and p-menta-1, 4-dien-7-al from the essential oil of Cuminum cyminum L. by high-speed counter-current chromatography. Anal Chim Acta 2011; 689: 149-154
• 20 Thappa RK, Ghosh S, Agarwal SG. et al. Comparative studies on the major volatiles of Kalazira (Bunium persicum seed) of wild and cultivated sources. Food Chem 1991; 41: 129-134
• 21 Lee HS. Cuminaldehyde: Aldose reductase and alpha-glucosidase inhibitor derived from Cuminum cyminum L. seeds. J Agric Food Chem 2005; 53: 2446-2453
• 22 Qarabadeen Majeedi (Unani Pharmacopeia in Urdu version). 1986. 9th Edition, p 136
• 23 Hudaib M, Speroni E, Pietra AMDi. et al. GC/MS evaluation of thyme (Thymus ulgaris L.) oil composition and variations during the vegetative cycle. J Pharm Biomed Anal 2002; 29: 691-700
• 24 Sivarajan VV, Balachandran I. Ayurvedic Drugs and their Plant Sources. New Delhi: Oxford and IBH Publication; 1994
• 25 Shaw RS, Nihal M, Ahmad N. Dose translation from animal to human studies Revisited. FASEB 2007; 22: 659-661
• 26 Birari RB, Gupta S, Mohan GC. et al. Antiobesity and lipid lowering effects of Glycyrrhiza chalcones: Experimental and computational studies. Phytomedicine 1995; 18: 795-801
• 27 Ukwuani AN, Abukakar MG, Shehu RA. et al. Antiobesity Effects of Pulp Extract Tamarindus indica in Albino Rat. Asian J Biochem 2008; 3: 221-227
• 28 Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502
• 29 Hsu CL, Yen GC. Effect of Gallic acid on high fat diet-induced dyslipidaemia, hepatosteatosis and oxidative stress in rats. Br J Nutr 2007; 98: 727-735
• 30 Chang S, Graham B, Yakubu F. et al. Metabolic differences between obesity-prone and obesity-resistant rats. Am J Physiol 1990; 259: R1103-R1110
• 31 Ahren B, Scheurink AJ. Marked hyperleptinemia after high-fat diet associated with severe glucose intolerance in mice. Eur J Endocrinol 1998; 139: 461-467
• 32 Carroll JF, Zenebe WJ, Strange TB. Cardiovascular function in rat model of diet-induced obesity. Hypertension 2006; 48: 65-72
• 33 Hassan A, Nauman M, Anjum FM. et al. Comparative study on chemical composition and antioxidant activity of ginger (Zingiber officinale) and Cumin (Cuminum cyminum). J Agric Food Chem 2010; 58: 8231-8237
• 34 Ardekani MJ, Akbarian Z, Nazarian A. Effects of cumin (Cuminum cyminum L.) oil on serum glucose and lipid levels of rats. JSSU 2010; 19: 388-397
• 35 Samojlik I, Lakic N, Mimica-Dukic N. et al. Antioxidant and hepatoprotective potential of essential oils of coriander (Coriandrum sativum L.) and caraway (Carum carvi L.) (Apiaceae). J Agric Food Chem 58 2010; 58: 8848-8853
• 36 Takahashi Y, Inaba N, Kuwahara S. et al. Effects of gamma-terpinene on lipid concentrations in serum using Triton WR1339-treated rats. Biosci Biotechnol Biochem 2003; 67: 2448-2450
• 37 Haque MR, Ansari SH, Najmi AK. et al. Monoterpene phenolic compound thymol prevents high fat diet induced obesity in murine model. Toxicol Mech Methods 2014; 24: 116-123
• 38 Matsuo T, Takeuchi H, Suzuki H. et al. Body fat accumulation is greater in rats fed a beef tallow diet than in rats fed a safflower or soybean oil diet. Asia Pac J Clin Nutr 2002; 11: 302-308
• 39 Corbett SW, Stern JS, Keesey RE. Energy expenditure in rats with diet-induced obesity. Am J Clin Nutr 1986; 44: 173-180
• 40 Lavie CJ, Milani RV. Obesity and cardiovascular disease: hippocrates paradox?. J Am Coll Cardiol 2003; 42: 677-679
• 41 Han LK, Xu BJ, Kimura Y. et al. Anti-obesity effects in rodents of dietary tea saponin, a lipase inhibitor. Int J obes relat metab disord 2001; 25: 1459-1564
• 42 Hsu CL, Yen GC. Effect of Gallic acid on high fat diet-induced dyslipidaemia, hepatosteatosis and oxidative stress in rats. Br J Nutr 2007; 98: 727-735
• 43 Bobek P, Hromadova M, Ozdin L. Effect of oyster mushroom (Pleurotus ostreatus) and its ethanolic extract in diet on absorption and turnover of cholesterol in hypercholesterolemic rat. Mol Nutr Res 1996; 40: 589-591
• 44 Zhi J, Melia AT, Guerciolini R. et al. Retrospective population-based analysis of the dose-response (fecal fat excretion) relationship of orlistat in normal and obese volunteers. Clin Pharmacol Ther 1994; 56: 82-85
• 45 Saltiel AR. Series Introduction: The molecular and physiological basis of insulin resistance: emerging implications for metabolic and cardiovascular diseases. Journal of Clinical Investigation 2000; 106: 163-164
• 46 Huang H, Xu Y. NA et al. Nicotine excites hypothalamic arcuate anorexigenic proopiomelanocortin neurons and orexigenic neuropeptide Y neurons: similarities and differences. J Neurophysiol 2011; 106: 1191-1202
• 47 Wang Y, Kuropatwinski KK, White DW. et al. Leptin receptor action in hepatic cells. J Biol Chem 1997; 272: 16216-16223
• 48 Sharma N, Sharma VK, Seo SY. Screening of some medicinal plants for anti-lipase activity. J Ethno pharmacol 2005; 97: 453-456
• 49 Adams LA, Sanderson S, Lindor KD. et al. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J Hepatol 2005; 42: 132-138
• 50 Roden M, Anderwald C, Furnsinn C. et al. Effects of short-term leptin exposure on triglyceride deposition in rat liver. Hepatology 2000; 32: 1045-1049